trending Market Intelligence /marketintelligence/en/news-insights/trending/zFHr3gpQmKJTgmbw1uBM8w2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Marinus raises $70M from common stock offering, private placement

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Marinus raises $70M from common stock offering, private placement

Marinus Pharmaceuticals Inc. said it raised approximately $70 million from a private and a public offering after underwriters of its previously announced offering fully exercised their overallotment option.

The Radnor, Pa.-based pharmaceutical company sold 32,200,000 shares at $1.25 apiece, including the additional 4,200,000 shares as part of underwriters' overallotment option.

The gross proceeds of $70 million includes a concurrent purchase of up to $30 million of the company's common stock by private investors.

Oppenheimer & Co. Inc. and Ladenburg Thalmann & Co. Inc. were the joint book-running managers for the offering, while Craig-Hallum Capital Group LLC acted as co-manager.

The company aims to use the net proceeds to develop its experimental drug ganaxolone for rare seizure disorders. The drug failed to beat the placebo in the second part of a mid-stage clinical trial in postpartum depression in July.